On the surface it seems she should be. She is Vice President and General Counsel of Boston Scientific’s cardiovascular division, and as such works inside the pulsating heart of a $5.6 billion publicly traded corporation (NYSE: BSX). Boston Scientific has 16,000 employees worldwide—with a hearty 3,000 in Plymouth and Maple Grove, Minn., including Lance, helping manufacture, develop and market lifesaving medical devices.
Primarily, she serves as an in-house attorney. The medical device she personally helped launch in 2004, the complicated sounding TAXUS® Express2™ Paclitaxel-Eluting Coronary Stent System, has been offering genuine hope for millions of Americans with blocked heart arteries. Earlier this year, Boston Scientific announced the millionth sale and implantation of that particular stent, nearly doubling the corporation’s revenue.